The microbiome isn’t a list of species.

It’s a living ecosystem. It should not be measured by testing fragments in isolation. The whole picture matters.

‍

A healthy gut microbiome requires a balanced ecosystem

Like any ecosystem, a healthy gut microbiome is a balanced one. Evaluating that balance cannot be reduced to a list of well-known species. It emerges from complex microbial interactions across the whole ecosystem, from diversity to environment

Most tests only measure a partial view of that ecosystem

Most testing technologies measure only fragments of this ecosystem, evaluating a partial list of well-known species and attempt to infer "balance" from that partial view. If the clinical question is ecosystem balance, the measurement must reflect the ecosystem.

Species-level detection

Measures the presence or absence of individual organisms in isolation - no diversity data, no functional insight, no understanding of how the community behaves as a whole.

Whole ecosystem assessment

Captures the full community picture: diversity, relative abundance, functional capacity, and the physiological conditions that shape how the microbiome actually functions.

‍

Partial testing can’t reliability answer critical clinical questions

How does this organism’s abundance compare to the overall ecosystem?

Is the ecosystem resilient or vulnerable to instability? ²³

Is functional capacity reduced?

Is it contributing to an anti-inflammatory or pro-inflammatory state?

‍

Ecosystem balance emerges from the whole system; targeted tests are inherently limited in scope.²

‍

Ecosystem-level assessment unlocks critical patient insights.

In practice, microbiome testing is about more than detecting which species are present. The goal is interpretation: understanding how the microbiome may be influencing symptoms, inflammation, gut barrier function, and metabolic signalling

‍

Testing technologies vary in what they can measure and reveal

‍

The critical shift: metagenomics enables ecosystem-level assessment. Because it captures the full genetic content of the community. ⁵ Not just selected fragments

‍

Ecosystem-level assessment reveals functional capacity

Clinical impact is determined not just by which organisms are present, but by what the ecosystem is functionally doing within the body. We call this functional capacity.

Examples include

• Short-chain fatty acid production (e.g. butyrate), which supports immune regulation and barrier integrity.⁵

• Lipopolysaccharide (LPS) signalling potential from Gram-negative organisms, associated with inflammatory activation.⁸

• Mechanisms influencing gut barrier permeability.

‍

Functional capacity refers to the collective ability of the microbial community to carry out key biological activities.

‍

Without insights into the functional capacity of the microbiome, clinicians are left interpreting microbial composition alone, which often fails to explain chronic symptoms or relapsing presentation.

‍

Whole-ecosystem testing supports more informed clinical decision-making

Whole-ecosystem testing fundamentally changes how clinicians think about patient symptoms. It moves the clinical question from “what organism is present?” to “how is this ecosystem functioning, and what is it driving?” This is where clinical-grade testing comes in.

‍

Clinical-grade testing requires more than technology

Whole-community sequencing is a necessary foundation, but clinical application requires more.
Metagenomics is only clinically meaningful when results are accurate, reproducible, and interpretable. For that, the technology has to be embedded in validated, accredited systems. Technology alone doesn't deliver clarity. Integrated systems do.

001

Validated sample collection and preservation

002

Accredited laboratory standards (e.g. ISO 15189)

003

High-quality bioinformatics pipelines⁷

004

Evidence-based interpretation frameworks

‍

‍

The most accurate picture requires the right combination of technologies

No single method answers every clinical question. To deliver true ecosystem insight, testing must integrate:

- Shotgun metagenomics for full community and functional capacity⁵

- Validated Gut health markers to assess gut barrier function and inflammation

- PCR for targeted pathogen confirmation

‍

Practical summary

Microbiome balance is an ecosystem property within the gut environment. ¹²

• Partial testing measures fragments, not systems.
• Functional capacity determines clinical impact. ⁵
• Ecosystem-level understanding requires whole-community measurement.
• Clinical-grade clarity requires validated systems, not just sequencing.
• If the goal is confident, actionable insights, then the whole ecosystem must be